Disclosure under SEBI Takeover Regulations

Nath Bio-Genes (India) Limited has informed the exchanges about the submission of its annual disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This filing, made by the company's promoters for the financial year ended March 31, 2026, pertains to details of any shares encumbered (e.g., pledged). While the specific details of encumbrances are not provided in this announcement, it signifies the company's compliance with regulatory requirements concerning promoter shareholdings. Investors often monitor such disclosures for insights into promoter commitment and financial standing.